跳至主要内容
临床试验/NL-OMON47431
NL-OMON47431已完成4 期

REMission INDuction in very early Rheumatoid Arthritis - REMINDRA

niversitair Medisch Centrum Utrecht0 个研究点目标入组 267 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
267

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • To be eligible to participate in this study, a subject must meet all of the following criteria:
  • - Able and willing to give written informed consent
  • - At least 18 years of age
  • - Fulfilling 2010 ACR/EULAR criteria for RA (Appendix A.)
  • - Patient reported symptom duration (joint stiffness, tenderness, pain, and/or swelling) < 12 months
  • - Naïve for DMARD and biological treatment
  • - DAS28 <=>3.2
  • - Have sufficient knowledge of the Dutch language to be able to comply with the requirements of the study protocol

排除标准

  • A potential subject who meets any of the following criteria will be excluded from participation in this study:
  • - Having used glucocorticoids < 6 weeks before the baseline visit
  • - Being pregnant (based on anamnesis) or a nursing women or a women of child bearing potential without (adequate) use of contraception
  • - Having any other inflammatory rheumatic disease than RA, except for secondary Sjögren*s syndrome
  • - Having contraindications for the use of MTX/HCQ/methylprednisolone/GOL.

研究者

发起方
niversitair Medisch Centrum Utrecht

相似试验

REMission INDuction in very early Rheumatoid... | 临床试验